ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
38 announcements
Themis Medicare has filed a revised September 2026 quarter shareholding pattern. It reclassifies trustees as promoter group and adds OSS Software Solutions as a nil-holding promoter group member.
Themis Medicare's board is scheduled for November 5, 2026, to approve quarterly and half-year financial results. The trading window remains closed until 48 hours post-results publication.
Promoter Vividhmargi pledged 15 lakh Themis Medicare shares for a Rs 135 Crore borrowing. Total encumbrance rises to 4.89% of capital.
Themis Medicare proposes re-appointing Independent Director Bhaskar Vemban Iyer for a second five-year term from 12 November 2026. Postal ballot notice dispatched to members seeking approval.
Themis Medicare seeks shareholder approval via postal ballot for a special resolution re-appointing Mr. Bhaskar Iyer as Independent Director for a second five-year term. Remote e-voting runs 24 October to 22 November 2026.
Themis Medicare Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI Regulation 31(1)(b).
CARE Ratings downgraded Themis Medicare's long-term and short-term bank facility ratings. The downgrade reflects deteriorating profitability, heightened competition, and weak debt coverage indicators.
Themis Medicare Ltd filed its quarterly shareholding pattern for the period ended June 30, 2026. This is a routine regulatory disclosure under Regulation 31.
Themis Medicare Ltd reported a promoter group reorganization. Vividhmargi Trust acquired a 27.49% stake from individual promoters through an off-market settlement.
Themis Medicare received a credit rating downgrade from CARE Ratings for its long-term (CARE BB+; Stable) and short-term (CARE A4+) bank facilities.
Themis Medicare Limited shareholders approved a dividend of Rs. 0.50 per share, totaling Rs. 4.61 Crore. The meeting also approved amendments to the company's Articles of Association.
Themis Medicare Limited conducted its 56th Annual General Meeting on September 30, 2026. Shareholders considered financial statements, director re-appointment, dividend declaration, and an amendment to the Articles of Association.
Themis Medicare Ltd withdrew its proposed preferential issue of 45,95,795 warrants. The company secured working capital through alternative means, and no adverse impact is expected.
Themis Medicare fixed the record date as September 23, 2026, for its final dividend FY 2025-26, pending AGM approval on September 30, 2026. No dividend per-share amount is stated.
Themis Medicare Limited has issued the notice for its upcoming Annual General Meeting scheduled for September 30, 2026. Shareholders will consider resolutions including dividend declaration.
Themis Medicare Limited has filed its Annual Report for the financial year 2025-26, along with the notice for its 56th Annual General Meeting.
Themis Medicare Limited has clarified to the exchange that there is no pending or delayed material information regarding the recent increase in trading volume.
Themis Medicare has appointed Suresh Savaliya as Company Secretary and Compliance Officer, replacing Nagraj Mogoveera, who transitioned to another role within the company.
Themis Medicare Q1 FY27 revenue hit ₹86.96 Cr with 28.3% PAT margin, significantly boosted by one-off gains of ₹92.95 Cr from share sales.
Themis Medicare Ltd has updated its list of authorized persons responsible for determining the materiality of information and disclosures under SEBI Regulation 30(5).
Themis Medicare Ltd reported revenue from operations of ₹87 Cr (-10.9% YoY) and net profit of ₹24.6 Cr for Q1 FY27.
Themis Medicare Ltd has scheduled a board meeting for August 13, 2026, to approve the standalone and consolidated financial results for the quarter ending June 30, 2026.
Vividhmargi Investments Private Limited, a promoter of Themis Medicare Limited, created a pledge of 30,00,000 equity shares. The pledge represents 3.26% of the company's total share capital.
Themis Medicare Ltd filed its quarterly shareholding pattern for the period ended June 30, 2026. The report includes explanatory notes regarding prior internal promoter group restructuring.
Themis Medicare Ltd filed its quarterly shareholding pattern for the period ended June 2026, noting internal promoter group entity restructuring and shareholding consolidation.
Promoter Vividhmargi Trust created a pledge over 2.53 crore shares of Themis Medicare Ltd as collateral for a ₹135 Crore loan facility.
Vividhmargi Investments Private Limited released a pledge on 15,00,000 equity shares of Themis Medicare. This reduces the promoter group's total encumbered stake to nil.
Pharmaceutical Business Group (India) Limited reported an indirect encumbrance on 47.02% of Gujarat Themis Biosyn's equity. This follows a pledge creation by Vividhmargi Investments.
Vividhmargi Trust pledged 2.53 crore Themis Medicare shares valued at Rs.28.42 Crore. The pledged shares, 27.49% of total, secure a Rs.135 crore loan for personal use.
CTL Trusteeship Ltd disclosed a pledge over 27.49% of Themis Medicare's shares. The pledge, effective June 29, 2026, secures debentures issued by OSS Software Solutions Labs.